AVEO
AVEO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Business Model:
Revenue: $94.3M
Employees: 51-200
Industries / Tags:
Detailed AVEO Information
Geographic Data
Address: 30 Winter Street
City: Boston
State: MA
Zip: 02108
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$55M
Raised Total:$379M
Social
Metrics
3,148,562Website Global Rank
5,190Website Monthly Traffic
Twitter Followers
Description
AVEO is a Massachusetts-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of cancer.
Contact Phone:
+18574000101
Contact Email:
AVEO went public on 3/12/2010 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
3/12/2010
IPO Valuation:
$415M
Ticker Symbol:
AVEO
IPO Price:
$9/share
Amount Raised:
$81M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
